From July 30 to August 1, 76th ADLM 2024 is holding now at McCormick Place Convention Center in Chicago, IL, USA, attracting a large number of professionals, leaders, and representative enterprises from all around the world, who engage in diagnostics and laboratory medicine communities. As an old friend of ADLM, Dymind is excited to showcase the latest advancements and comprehensive solutions to healthcare on this grand stage.

With pioneering innovation for further healthcare, Dymind brings a comprehensive range of healthcare solutions to booth No.1853, covering the fields of hematology, coagulation, immunoassay, POCT and veterinary.

On the first day, Dymind's booth was bustling with participants as it showcased the DH-8000, the new-generation automatic hematology analysis line, and DH-800, the upgraded auto hematology analyzer with AI technology, aiming to provide more accurate and efficient diagnosis.

During this event, Dymind officially lunched innovative products and the latest technical advantages, focusing on high-end hematology analyzer with AI applications , DH-800, and the novel multiplex platform for allergy and autoimmunity testing, MF1280. With professional presentation, Dymind attracted numerous participants with high praise for our technological breakthroughs.

In the academic poster section, more details of MF1280 were shown for participants. While ensuring result accuracy, MF1280 delivers rapid results for all tested items within a single test portfolio, significantly increasing diagnostic efficiency.

The fully automated coagulation analyzer, CA1200, combines the optical and mechanical methods for clotting assays, while being able to intelligent switch from two methods when abnomal sample is detected, to ensures both test accuracy and cost-effectiveness.

Apart from that, the veterinary solutions including automatic AI morphology analyzer, D-wise, 5-part automatic hematology analyzer with RET, DM61 Vet and POCT hematology analyzer, DP-H10 Vet received rave reviews during the event.

The innovative DP-H50, an automatic 5-part hematology analyzer that integrates immunoassay and chemistry, was publicly showcased for the first time at ADLM 2024 and made a splash with onsite customers. With capabilities for joint tests in CBC, immunofluorescence, colloidal gold, and the chemistry module, the DP-H50 offers 5 test modes with single-package reagent to meet diverse demands.

Through its participation in this event, Dymind has established connections, cooperation, and trust with clients. In the future, Dymind aims to share more innovative practices in laboratory medicine, sophisticated designs for various scenarios, and broaden the clinical value boundaries of laboratories, offering more groundbreaking solutions in the field of healthcare worldwide.

ADLM 2024 ended successfully! Please look forward to ADLM 2025 in Chicago, featuring more innovations in healthcare and cutting-edge technologies from Dymind. We are eager to our next meeting!